Clinical Trial Update: Conjugate Vaccine Against Meningococcus C a Brazilian Project [Phase 2, Phase 3]

View source ↗

Summary

A Brazilian trial update for a conjugate vaccine targeting Serogroup C meningococcal meningitis in Phase 2/Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Serogroup Meningococcal Meningitis

Drugs mentioned

• Conjugate Vaccine Against Meningococcus C

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Serogroup C Meningococcal Meningitis | Phase 2, Phase 3 | Status: UNKNOWN